LOW PROFILE PORT ATTACHABLE CATHETER WITH BLUE FLEX TIP / 8FR. INRODUCER KIT IMPLANTABLE VASCULAR ACCESS SYSTEM
K981782 · Arrow Intl., Inc. · DYB · Aug 12, 1998 · Cardiovascular
Device Facts
Record ID
K981782
Device Name
LOW PROFILE PORT ATTACHABLE CATHETER WITH BLUE FLEX TIP / 8FR. INRODUCER KIT IMPLANTABLE VASCULAR ACCESS SYSTEM
Applicant
Arrow Intl., Inc.
Product Code
DYB · Cardiovascular
Decision Date
Aug 12, 1998
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.1340
Device Class
Class 2
Attributes
Therapeutic
Intended Use
The Low Profile Port system is indicated whenever patient therapy requires repeated intravascular injection or continuous infusion of fluids, medications, antibiotics, nutritionals, and the withdrawal of venous blood samples.
Device Story
Low Profile Port system is an implantable vascular access device; facilitates repeated intravascular injection or continuous infusion of fluids, medications, antibiotics, and nutritionals; enables venous blood sampling. Device consists of an attachable catheter with a Blue Flex Tip and an introducer kit. Used in clinical settings by healthcare professionals for patients requiring long-term venous access. Provides a stable, reliable port for therapeutic delivery and diagnostic sampling; reduces need for repeated venipuncture; improves patient comfort and safety during chronic therapy.
Clinical Evidence
No clinical data provided; substantial equivalence determination based on regulatory review of device specifications and intended use.
Technological Characteristics
Implantable vascular access system; includes attachable catheter with Blue Flex Tip; 8Fr introducer kit. Materials and design consistent with established vascular access standards. Non-electronic, mechanical device.
Indications for Use
Indicated for patients requiring repeated intravascular access for fluid/medication infusion (including antibiotics and nutritionals) or venous blood sampling.
Regulatory Classification
Identification
A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.
Related Devices
K031282 — OPTILOCK IMPLANTABLE ACCESS PORT, MODEL 1700-05 · LeMaitre Vascular, Inc. · Aug 5, 2003
K993024 — CELSITE IMPLANTABLE PORT WITH VALVED CATHETER · B. Braun of America, Inc. · Mar 13, 2000
K964538 — R-PORT STANDARD IMPLANTABLE VASCULAR ACCESS SYSTEM · Boston Scientific Corp · Mar 10, 1997
K994111 — CELSITE, MODELS ST401L, ST405L · B. Braun/Mcgaw · Jan 3, 2000
K962230 — CELSITE PORT WITH PRECONNECTED CATHETER · B.Braun Medical, Inc. · Dec 16, 1996
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the United States Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle with its wings spread.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 1 2 1998
Mr. Bradley J. Enegren Arrow International, Inc. 1600 Providence Highway Walpole, MA 02081
K981782 Re: Low Profile Port® Attachable Catheter with Blue Flex Tip®/8Fr. Introducer Kit Implantable Vascular Access System Regulatory Class: II (two) Product Code: 74 DYB Dated: May 18, 1998 Received: May 20, 1998
Dear Mr. Enegren:
We have reviewed your Section 510 (k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Requlation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such Failure to comply with the GMP regulation may result in assumptions. regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{1}------------------------------------------------
## Page 2 - Mr. Bradley J. Enegren
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
sincerely yours,
Thomas J. Callahon
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
501(K) Number (if known):
Device Name:
Low Profile Plastic Port Attachable Catheter with Blue Flex Tip® System / Introducer Kit
Indications For Use:
The Low Profile Port system is indicated whenever patient therapy requires repeated intravascular injection or continuous infusion of fluids, medications, antibiotics, nutritionals, and the withdrawal of venous blood samples.
Tan A. h
(Division Sign-Off) Division of Concessoular, Respiratory, and Neuts of the reservices 510(k) Number ..
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use | V |
|----------------------|---|
| (Per 21 CFR 801.109) | |
OR
Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________
(Optional Format 1-2-96)
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.